CA1021261A - Herpes simplex type 2 virus vaccine and method of production and use - Google Patents
Herpes simplex type 2 virus vaccine and method of production and useInfo
- Publication number
- CA1021261A CA1021261A CA196,323A CA196323A CA1021261A CA 1021261 A CA1021261 A CA 1021261A CA 196323 A CA196323 A CA 196323A CA 1021261 A CA1021261 A CA 1021261A
- Authority
- CA
- Canada
- Prior art keywords
- production
- herpes simplex
- virus vaccine
- simplex type
- type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/821—Drug, bio-affecting and body treating compositions involving temperature-sensitive mutant virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1530773A GB1390467A (en) | 1973-03-30 | 1973-03-30 | Vaccination method using temperature sensitive virus mutants |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1021261A true CA1021261A (en) | 1977-11-22 |
Family
ID=10056766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA196,323A Expired CA1021261A (en) | 1973-03-30 | 1974-03-29 | Herpes simplex type 2 virus vaccine and method of production and use |
Country Status (10)
Country | Link |
---|---|
US (1) | US3897549A (de) |
JP (1) | JPS6035327B2 (de) |
BE (1) | BE812816A (de) |
CA (1) | CA1021261A (de) |
DE (1) | DE2415353A1 (de) |
FR (1) | FR2223004B1 (de) |
GB (1) | GB1390467A (de) |
HU (1) | HU169253B (de) |
NL (1) | NL7404054A (de) |
ZA (1) | ZA741441B (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4374127A (en) * | 1977-09-19 | 1983-02-15 | Merck & Co., Inc. | Herpes sub unit vaccine |
US4452734A (en) * | 1980-02-11 | 1984-06-05 | Merck & Co., Inc. | Herpes subunit vaccine |
US4554159A (en) * | 1981-11-12 | 1985-11-19 | Institute Merieux | Vaccine and method of immunizing against herpes simplex virus (types 1 and 2) |
US4618493A (en) * | 1982-10-13 | 1986-10-21 | Smithkline-Rit | Temperature sensitive strains of bovine viral diarrhoea virus, preparation thereof and vaccines containing them |
US4714678A (en) * | 1982-10-13 | 1987-12-22 | Smithkline-Rit | Temperature sensitive strain of bovine viral diarrhoea virus |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4848621A (de) * | 1971-10-20 | 1973-07-10 | ||
DE2215728C3 (de) * | 1972-03-30 | 1979-02-15 | Stickl, Helmut, Prof. Dr.Med., 8033 Krailling | Arzneimittel zur Behandlung von Herpes simplex |
-
1973
- 1973-03-30 GB GB1530773A patent/GB1390467A/en not_active Expired
-
1974
- 1974-03-05 ZA ZA00741441A patent/ZA741441B/xx unknown
- 1974-03-07 US US44885074 patent/US3897549A/en not_active Expired - Lifetime
- 1974-03-25 FR FR7410112A patent/FR2223004B1/fr not_active Expired
- 1974-03-26 BE BE142433A patent/BE812816A/xx not_active IP Right Cessation
- 1974-03-26 NL NL7404054A patent/NL7404054A/xx unknown
- 1974-03-29 DE DE2415353A patent/DE2415353A1/de active Granted
- 1974-03-29 CA CA196,323A patent/CA1021261A/en not_active Expired
- 1974-03-29 HU HURE000548 patent/HU169253B/hu unknown
- 1974-03-29 JP JP49036567A patent/JPS6035327B2/ja not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FR2223004B1 (de) | 1978-01-06 |
JPS6035327B2 (ja) | 1985-08-14 |
JPS5029736A (de) | 1975-03-25 |
AU6708674A (en) | 1975-09-25 |
ZA741441B (en) | 1975-02-26 |
NL7404054A (de) | 1974-10-02 |
FR2223004A1 (de) | 1974-10-25 |
DE2415353C2 (de) | 1987-10-01 |
US3897549A (en) | 1975-07-29 |
HU169253B (de) | 1976-10-28 |
GB1390467A (en) | 1975-04-16 |
BE812816A (fr) | 1974-09-26 |
DE2415353A1 (de) | 1974-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1028265A (en) | Process for the preparation of r-carbamyl-amino acids and of the corresponding r-amino acids | |
CA1021261A (en) | Herpes simplex type 2 virus vaccine and method of production and use | |
SU579309A1 (ru) | Способ получени вакцины | |
CA1023371A (en) | Xanthene derivatives and process for the preparation thereof | |
AU486997B2 (en) | Herpes simplex type 2 virus vaccine and method of production and use | |
CA1031774A (en) | Water-soluble derivative of 6-deoxy-tetracyclines and process for the preparation thereof | |
CA1011337A (en) | Piperazine derivatives and their process of preparation | |
CA1005073A (en) | Acylamino alkanol derivatives and process for preparation thereof | |
AU464457B2 (en) | 6-trichloroacetamido-penicillanic acid derivatives and their preparation | |
CA975976A (en) | Thawer-cooker and method of using the same | |
AU458654B2 (en) | Pyrimidine derivatives and their methods of preparation | |
AU478312B2 (en) | New triazolobenzodiazepines and process for their preparation | |
AU477725B2 (en) | Process and preparation of prostaglandins | |
AU485763B2 (en) | V-p-zr catalysts and method of preparation thereof | |
AU479786B2 (en) | New arylipiperazine derivatives of adenine and the preparation thereof | |
AU481190B2 (en) | Disteroidyl-ethers and process | |
CA867399A (en) | Dyestuffs of the triphenylrosaniline series and process for their preparation | |
AU484291B2 (en) | Prostatrienoic acid derivatives and process | |
AU7143174A (en) | Dibenzoxepin derivatives and process forthe preparation thereof | |
AU483880B2 (en) | Process for the preparation of 2-nitrobenzalpehyde and 2-nitrobenzylidenech-loride | |
AU483268B2 (en) | Dibenzoxepin derivatives and process forthe preparation thereof | |
AU493525B2 (en) | Benzhydryloxy-alkylamine derivatives and process forthe preparation thereof | |
AU479364B2 (en) | ADENINE DERIVATIVES AND PREPARATION thereof | |
AU477684B2 (en) | Novel phenoxyalkylamine derivatives and preparation thereof | |
AU478543B2 (en) | Radiation polymerizable composition and process |